Caterina Di Sano Selected Research

Caterina Di Sano Research Topics

Disease

10	Inflammation (Inflammations) 03/2019 - 01/2008
8	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 12/2013
6	Neoplasms (Cancer) 06/2022 - 09/2003
5	Asthma (Bronchial Asthma) 01/2016 - 01/2012
3	Lung Neoplasms (Lung Cancer) 02/2022 - 02/2014
2	Adenocarcinoma of Lung 06/2022 - 02/2022
2	Adenocarcinoma 06/2022 - 02/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 02/2014
2	Melanoma (Melanoma, Malignant) 10/2020 - 11/2019
2	Allergic Rhinitis 01/2019 - 08/2015
2	Rhinitis 08/2015 - 01/2013
2	Infections 08/2003 - 10/2002
2	Tuberculosis (Tuberculoses) 12/2002 - 10/2002
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2021
1	Insulin Resistance 01/2021
1	Lung Diseases (Lung Disease) 04/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Reinfection 11/2017
1	Colonic Neoplasms (Colon Cancer) 08/2017
1	Chronic Disease (Chronic Diseases) 11/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016
1	Mucoepidermoid Carcinoma 08/2014
1	Leukemia 06/2013
1	Malignant Pleural Effusion 01/2011
1	Heart Failure 01/2011
1	Pleural Effusion (Pleural Effusions) 01/2011
1	Shwartzman Phenomenon (Shwartzman Reaction) 03/2007
1	Septic Shock (Toxic Shock Syndrome) 03/2007
1	Shock 03/2007

Drug/Important Bio-Agent (IBA)

6	SmokeIBA 02/2022 - 12/2015
6	Interleukin-17 (Interleukin 17)IBA 01/2016 - 01/2013
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018 - 12/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 10/2021 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 12/2002
2	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 01/2016
2	GlucocorticoidsIBA 11/2016 - 01/2016
2	LipopolysaccharidesIBA 11/2016 - 03/2007
2	CytokinesIBA 12/2015 - 03/2007
2	olodaterolIBA 05/2014 - 12/2013
2	Tiotropium Bromide (Spiriva)FDA Link 05/2014 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 08/2003
1	LycopeneIBA 06/2022
1	PhytochemicalsIBA 06/2022
1	oleoresinsIBA 06/2022
1	AntioxidantsIBA 06/2022
1	Carotenoids (Carotene)IBA 06/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Annexin A5IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 10/2020
1	Olive OilIBA 10/2020
1	Halogenated Diphenyl EthersIBA 04/2020
1	tetraphenylporphine sulfonate (TPPS)IBA 11/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019
1	di-n-butyltin (dibutyltin)IBA 11/2019
1	adhesion receptorIBA 11/2019
1	Cyclin D1IBA 11/2019
1	tributyltinIBA 11/2019
1	Lysine (L-Lysine)FDA Link 10/2019
1	Histones (Histone)IBA 10/2019
1	VimentinIBA 10/2019
1	2,2',4,4'-tetrabromodiphenyl etherIBA 03/2019
1	LeptinIBA 01/2019
1	AdipokinesIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	MLN2238IBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	ixazomibIBA 01/2018
1	oleocanthalIBA 08/2017
1	SteroidsIBA 11/2016
1	InflammasomesIBA 11/2016
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2016
1	LipoxinsIBA 01/2016
1	lipoxin A4IBA 01/2016
1	U 0126 (UO 126)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Leukotriene B4IBA 01/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	Mucin 5ACIBA 08/2014
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2014
1	Interleukin-22 (IL-22)IBA 05/2014
1	Caspase 3 (Caspase-3)IBA 02/2014
1	Caspase 8 (Caspase-8)IBA 02/2014
1	Fas Ligand Protein (Fas Ligand)IBA 02/2014
1	Gemcitabine FDA Link 02/2014
1	Pharmaceutical PreparationsIBA 12/2013
1	Bronchodilator Agents (Bronchodilators)IBA 12/2013
1	Muscarinic AntagonistsIBA 12/2013
1	3-nitrotyrosineIBA 12/2013
1	ChlorineIBA 06/2013
1	Formoterol Fumarate (Oxis)FDA Link 01/2013
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2013
1	PerforinIBA 01/2011
1	Fibril-Associated Collagens (FACIT Collagen)IBA 01/2008
1	Interleukin-10 (Interleukin 10)IBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	LigandsIBA 03/2007

Therapy/Procedure

1	Therapeutics 01/2016
1	Drug Therapy (Chemotherapy) 02/2014